|$CBDL CBD Life Sciences, Inc. (CBDL) Debuts New Delta-9 Gummies|
SCOTTSDALE, AZ / ACCESSWIRE / April 5, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is introducing new powerful Delta-9 Gummies.
LBC Bioscience Inc. is always producing products to satisfy customers and this product is over the top outstanding! The improved gummies the company is introducing are Raspberry Sherbet flavored packed with 200MG of Delta-9 and 400MG of CBD. LBC's Gummies use a harmonizing 2:1 blend of CBD and Delta-9 for an overall balanced, elevated experience. The two hemp-derived cannabinoids work together well, helping bring you to center by quieting busy thoughts. These gummies are ideal for easing the mind while having staying focused all at the same time! All products are carefully blended to ensure consistency along with Third Party Lab Testing for verification. This product will be available in store as well as the LBC website within the next couple of weeks. President & CEO Lisa Nelson states "We are thrilled to be able to launch this product to consumers right away and we are also revamping our e-commerce website for a better fresh experience and will keep the public updated moving forward!"
The number of benefits CBD has is tremendous! These benefits may help with behavioral/neurological complications such as ADD/ADHD, anxiety, autism, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD may also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.